Connecticut Investments

Connecticut Innovations (CI) is the strategic venture capital arm of the State of Connecticut, serving as a leading source of financing and support for innovative early-stage companies. Founded in 1989, CI focuses on high-growth sectors including life sciences, information technology, and clean energy. The firm manages several specialized funds, such as the Connecticut Bioscience Innovation Fund (CBIF), which provides equity and loans to accelerate the commercialization of bioscience breakthroughs. CI's portfolio includes notable biotech successes like Alexion Pharmaceuticals, Arvinas, and Biohaven. In addition to capital, CI provides strategic guidance, introductions to partners, and access to a robust network of industry experts to help its portfolio companies thrive within the Connecticut ecosystem.